Published 3 August 2009, doi:10.1136/bmj.b3151
Cite this as: BMJ 2009;339:b3151
News
Philippines joins other developing countries in limiting prices of drugs
Ben Bland, Singapore
| The first 150 words of the full text of this article appear below. |
The Philippines is to impose price controls on some essential drugs, as the government seeks to reduce the cost of drugs that remain beyond the reach of large swathes of the population.
President Gloria Macapagal-Arroyo signed the executive order bringing in maximum retail prices on five key drugs on Monday 27 July. This followed the failure of a number of drug companies, including Pfizer, to cut prices by 50% in line with a new law designed to make them more affordable.
The Philippines, a third of whose population lives on less than $1 a day, is the latest developing country to resort to legal measures against drug companies in a bid to increase access to vital drugs.
"With this significant price reduction in leading essential products, we expect that it will alleviate the burden imposed by criminally high drug prices on our countrymen, particularly the poor," said Francisco Duque III,
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
StumbleUpon 
Technorati What's this?
This Article
- Full text
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Find similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Google Scholar
PubMed
Related Content
Bookmark with
What's new
Latest blogs
Find BMJ on:
Services
Tools
Online poll
Resources
Rapid responses for this article
There are no rapid responses for this article. Print issues
